aspirin has been researched along with alendronate in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Goodgame, R; Graham, DY; Malaty, HM | 1 |
| Bauer, DC; Lanza, F; Yates, AJ | 1 |
| Lanza, F; Lombardi, A; Rack, MF; Reyes, R; Simon, TJ; Suryawanshi, S | 1 |
| Bero, L; Henry, D; Lee, K; Mah, C; Moynihan, R; Ross-Degnan, D; Soumerai, SB; Watkins, J | 1 |
| Hunt, RH; James, C; Marshall, JK; Rainsford, KD | 1 |
| Deng, X; Endo, Y; Funayama, H; Kuroishi, T; Sasano, T; Sugawara, S; Yu, Z | 1 |
| Yee, J | 1 |
| Crozier, J; Massasso, D; Sharma, P; Tsai, TY | 1 |
| Collyer, JC; Ghazali, N; Tighe, JV | 1 |
| Hou, MC; Hu, HY; Lee, FY; Lin, HC; Luo, JC; Peng, YL | 1 |
1 review(s) available for aspirin and alendronate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for aspirin and alendronate
| Article | Year |
|---|---|
Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin.
Topics: Adult; Alendronate; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Double-Blind Method; Esophagus; Female; Gastric Mucosa; Gastroscopy; Humans; Male; Middle Aged; Stomach Ulcer | 1997 |
Effects of alendronate on gastric and duodenal mucosa.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Double-Blind Method; Duodenum; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Middle Aged | 1998 |
A randomized controlled trial to assess alendronate-associated injury of the upper gastrointestinal tract.
Topics: Adult; Alendronate; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dinoprostone; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Gastroscopy; Humans; Male; Middle Aged; Osteoporosis; Radioimmunoassay; Stomach Ulcer | 2000 |
10 other study(ies) available for aspirin and alendronate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Is alendronate clinically gastrotoxic? Re: Graham et al. primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin.
Topics: Adult; Alendronate; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Gastric Mucosa; Humans | 1998 |
Coverage by the news media of the benefits and risks of medications.
Topics: Alendronate; Anticholesteremic Agents; Aspirin; Biomedical Research; Cardiovascular Diseases; Conflict of Interest; Cost-Benefit Analysis; Disclosure; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Fees, Pharmaceutical; Humans; Journalism, Medical; Mass Media; Newspapers as Topic; Osteoporosis; Pravastatin; Risk Assessment; Television; United States | 2000 |
Comparative appraisal of clodronate, aspirin and dexamethasone as agents reducing alendronate-induced inflammation in a murine model.
Topics: Alendronate; Animals; Anti-Inflammatory Agents; Aspirin; Bone Density Conservation Agents; Clodronic Acid; Dexamethasone; Histidine Decarboxylase; Inflammation; Interleukin-1; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Organ Size; Radiography; Sclerosis; Spleen; Tibia | 2005 |
Chronic kidney disease--a disease domain complex.
Topics: Aged; Alendronate; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin; Bone Density Conservation Agents; Calcium; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy; Female; Glomerular Filtration Rate; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Kidney Failure, Chronic; Metoprolol; Nitroglycerin; Sulfonamides; Thiophenes | 2008 |
Taking PET for a walk - an unusual cause of bilateral leg claudication.
Topics: Alendronate; Anti-Inflammatory Agents; Aspirin; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Intermittent Claudication; Middle Aged; Prednisone; Radionuclide Imaging; Treatment Outcome | 2010 |
Hemimandibulectomy and vascularized fibula flap in bisphosphonate-induced mandibular osteonecrosis with polycythaemia rubra vera.
Topics: Aged, 80 and over; Alendronate; Aspirin; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Transplantation; Female; Fibrinolytic Agents; Fractures, Spontaneous; Humans; Magnetic Resonance Imaging; Mandibular Diseases; Mandibular Fractures; Mandibular Osteotomy; Phlebotomy; Plastic Surgery Procedures; Polycythemia Vera; Postoperative Complications; Skin Transplantation; Surgical Flaps; Treatment Outcome; Wound Healing | 2013 |
Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study.
Topics: Age Factors; Aged; Aged, 80 and over; Alendronate; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bone Density Conservation Agents; Case-Control Studies; Comorbidity; Confounding Factors, Epidemiologic; Databases, Factual; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Osteoporosis; Risk Factors; Sex Factors; Taiwan | 2014 |